Oncothyreon Inc (NASDAQ:ONTY)

Data as of Oct 22
 -0.13 / -6.84%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Oncothyreon, Inc. is clinical-stage bio-pharmaceutical company. The Company operates in a single business segment, Research and Development of therapeutic products for the treatment of cancer. Its cancer vaccines are designed to stimulate the immune system to attack cancer cells, while small molecule compounds are designed to inhibit the activity of specific cancer-related proteins. Oncothyreon was founded on September 7, 2007 and is headquartered in Seattle, WA.

Contact Information

Oncothyreon, Inc.
2601 4th Avenue
Seattle Washington 98121
P:(206) 801-2100
Investor Relations:



Other institutional34.94%
Individual stakeholders17.65%
Mutual fund holders16.70%

Top Executives

Robert L. KirkmanPresident, Chief Executive Officer & Director
Gary ChristiansonChief Operating Officer
Julia Marie EastlandCFO, Secretary & VP-Corporate Development
Scott Robert PetersonChief Scientific Officer
Diana HausmanChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.